跳至主要内容
临床试验/NL-OMON29602
NL-OMON29602尚未招募不适用

Short-course aminoglycosides as adjunctive treatment in adults with sepsis

niversity Medical Center Utrecht0 个研究点目标入组 3,140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
3,140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Age >= 18 years
  • 2) Presenting to the ER
  • 3) Suspicion of bacterial infection of unknown origin, primary suspected urinary origin or primary suspected abdominal origin.
  • 4) National Early Warning Score (NEWS) or Modified Early Warning Score (MEWS) = 5.
  • 5) Requiring intravenous antibiotic treatment and hospitalization.

排除标准

  • 1) Working diagnosis at the ER of pneumonia.
  • 2) Chemotherapy induced neutropenia as this is considered a separate entity in the guidelines.
  • 3) Pre-existing renal failure defined as a GFR < 30, due to a relative contra-indication for aminoglycosides.
  • 4) Allergy for cephalosporins or aminoglycosides, known prior to the start of treatment.
  • 5) Indication for empirical coverage of ESBL-producing gram-negative bacteria according to the Dutch sepsis guidelines, i.e. known colonization or infection with ESBL-producing gram-negative bacteria in the prior year.

研究者

相似试验